Not sure why you'd want some program arbitrarily seen through to completion when the landscape has changed.
The time for complaint was 18 months ago when Cullity sold shares and it became apparent both the IV formulation and cardio discovery were going to delay announced programs. The company only addressed these delays in March '22. Months after shareholders fronted up with ~$40m to enhance our opportunity.
I'm not going to complain now that we start to see the fruits of these painful delays.
@EWexplorer
I'm invested in the fundamentals and our maximum upside was just massively derisked. I don't see any material impact to the SP until the upside potential is blindingly obvious to the market (clinical validation or some BSD takes a large position).
Bring on Sheba 2.0 (they can then announce 3.0).
Not sure why you'd want some program arbitrarily seen through to...
-
- There are more pages in this discussion • 130 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.090(5.59%) |
Mkt cap ! $289.5M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.76 | $1.59 | $142.7K | 84.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17175 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.77 | 6060 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |